Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine

Journal of the American College of Cardiology

Volumn 32, Issue 4, 1998, Pages 904-911

  Quyyumi, Arshed A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DEXTRO ARGININE; INSULIN; PROLACTIN;

ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM; FEMALE; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TREADMILL EXERCISE; VASODILATATION;

ACETYLCHOLINE; AGED; ARGININE; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; EXERCISE TEST; FEMALE; FOREARM; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROLACTIN; STEREOISOMERISM; VASCULAR RESISTANCE; VASODILATION;

EID: 0032191376     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00323-4     Document Type: Article

References (47)

1. Mulcahy D., Dakak N., Zalos G., et al. Patterns and underlying mechanisms of transient myocardial ischemia in stable coronary artery disease are the same in both sexes a comparative study . J Am Coll Cardiol. 27:1996;1629-1636.
2. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide physiology, pathophysiology and pharmacology . Pharmacol Rev. 43:1991;109-141.
3. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
4. Zeiher A.M., Drexler H., Wollschläger H., Just H. Modulation of coronary vasomotor tone in humans Progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
5. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
6. Quyyumi A.A., Dakak N., Andrews N.P., et al. Nitric oxide activity in the human coronary circulation impact of risk factors for coronary atherosclerosis . J Clin Invest. 95:1995;1747-1755.
7. Quyyumi A.A., Dakak N., Mulcahy D., et al. Impaired release of nitric oxide from atherosclerotic human coronary vasculature. J Am Coll Cardiol. 29:1997;308-317.
8. Quyyumi A.A., Mulcahy D., Andrews N.P., Husain S., Panza J.A., Cannon R.O. III. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia comparison of acetylcholine and substance P . Circulation. 95:1997;104-110.
9. Quyyumi A.A., Cannon R.O., Panza J.A., Diodati J.G., Epstein S.E. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation. 86:1992;1864-1871.
10. Nabel E.G., Selwyn A.P., Ganz P. Paradoxical narrowing of atherosclerotic arteries induced by increases in heart rate. Circulation. 81:1990;850-859.
11. Gordon J.B., Ganz P., Nabel E.G., et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 83:1989;1946-1952.
12. Yeung A.C., Vekshtein V.I., et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 325:1991;1551-1556.
13. Girerd X.J., Hirsch A.T., Cooke J.P., Creager M.A. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res. 67:1990;1301-1308.
14. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzau V.J., Cooke J.P. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248-1253.
15. Rossitch E. Jr, Alexander E. III, Black P.M., Cooke J.P. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest. 87:1991;1295-1299.
16. Drexler H., Zeiher A.M., Meinertz T., Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 338:1991;1546-1550.
17. Dubois-Rande J.L., Zelinsky R., Rovoot F., et al. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol. 70:1992;1269-1275.
18. Quyyumi A.A., Dakak N., Diodati J., Gilligan D.M., Panza J.A., Cannon R.O. III. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol. 30:1997;1220-1227.
19. Tousoulis D., Davies G., Tentolouris C., Crake T., Toutouzas P. Coronary stenosis dilation induced by L-arginine. Lancet. 349:1997;1812-1813.
20. Panza J.A., Quyyumi A.A., Diodati J.G., Callahan T.S., Bonow R.O., Epstein S.E. Long-term variation in myocardial ischemia during daily life in patients with stable coronary artery disease its relation to changes in the ischemic threshold . J Am Coll Cardiol. 19:1992;500-506.
21. Panza J.A., Casino P.R., Badar D.M., Quyyumi A.A. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 87:1993;1475-1481.
22. Whitney R.J. Measurements of changes in human limb volume by means of a mercury-in-rubber starin gauge. J Physiol (Lond). 108:1948;5P-6P.
23. Glantz S.A., Slinker B.K. Repeated measures. Glantz S.A., Slinker B.K. Primer of Applied Regression and Analysis of Variance. 1990;381-463 McGraw-Hill, New York.
24. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol. 23:1994;844-850.
25. Dakak N, Hussain S, Mulcahy D, et al. Contribution of nitric oxide to reactive hyperemia: importance of endothelial dysfunction and effect of L-arginine. Hypertension 1998 (in press).
26. MacAllister R.J., Calver A.L., Collier J., et al. Vascular and hormonal responses to arginine provision of substrate for nitric oxide or nonspecific effect? Clin Sci. 89:1995;183-190.
27. Imaizumi T., Hirooka Y., Masaki H., et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension. 20:1992;511-517.
28. Clarkson P., Adams M.R., Powe A.J., et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 97:1996;1989-1994.
29. Bode-Boger S.M., Boger R.H., Creutzig A., et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci. 87:1994;303-310.
30. Hishikawa K., Nakaki T., Tsuda M., et al. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J. 33:1992;41-48.
31. Calver A., Collier J., Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci. 81:1991;695-700.
32. Palmer R.M.J., Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun. 158:1989;348-352.
33. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 685:1990;682-685.
34. Arnal J.-F., Münzel T., Venema R.C., et al. Interactions between L-arginine and L-glutamine change endothelial nitric oxide production An effect independent of nitric oxide synthase substrate availability . J Clin Invest. 95:1995;2565-2572.
35. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
36. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339:1992;572-575.
37. Bode-Boger S.M., Boger R.H., Kienke S., Juner W., Frohlich J.C. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 219:1996;598-603.
38. Boger R.H., Bode-Boger S.M., Brandes R.P., et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits Comparison with lovastatin . Circulation. 96:1997;1282-1290.
39. Boger R.H., Bode-Boger S.M., Mugge A., et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 117:1995;273-284.
40. Scherrer U., Randin D., Vollenweider P., Vollenweider L., Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 94:1994;2511-2515.
41. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest. 94:1994;1172-1179.
42. Schmidt H.H., Warner T.D., Ishi K., Sheng H., Murad F. Insulin secretion from pacreatic β-cells caused by L-arginine-derived nitrogen oxides. Science. 255:1992;721-723.
43. Anderson E.A., Mark A.L. The vasodilator action of insulin Implications for the insulin hypothesis of hypertension . Hypertension. 21:1993;136-141.
44. Giugliano D., Marfella R., Verrazzo G., et al. The vascular effects of L-arginine in humans. J Clin Invest. 99:1997;433-438.
45. Nagase S., Takemura K., Ueda A., et al. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun. 233:1997;150-153.
46. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon R.O. III. Contribution of nitric oxide to metabolic vasodilation in the human heart. Circulation. 92:1995;320-326.
47. Adams M.R., Forsyth C.J., Jessup W., Robinson J., Celermajer D.S. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol. 26:1995;1054-1061.